A Phase I Dose Escalation Study of BKM120 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
Clinical trial NCT01473901 · COMPLETED
Trial details
- NCT number
- NCT01473901
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-30
- Primary completion
- 2017-05-17
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.